|
|
|
Volumn 364, Issue 24, 2011, Pages 2360-2361
|
|
Bevacizumab for retinopathy of prematurity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BEVACIZUMAB;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
CAPILLARY HEMANGIOMA;
DISEASE SEVERITY;
DRUG INDICATION;
HUMAN;
INFANT;
LETTER;
LOW LEVEL LASER THERAPY;
MOTOR DYSFUNCTION;
NEUROLOGIC DISEASE;
NEUROMOTOR DISORDER;
PRIORITY JOURNAL;
RETROLENTAL FIBROPLASIA;
SPASTIC DIPLEGIA;
METHODOLOGY;
NEWBORN;
NOTE;
PREMATURITY;
BODY WEIGHT;
DRUG ANTAGONISM;
INTRAVITREAL DRUG ADMINISTRATION;
METABOLISM;
MORTALITY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
HUMANS;
INFANT, NEWBORN;
INFANT, PREMATURE;
LASER THERAPY;
RESEARCH DESIGN;
RETINOPATHY OF PREMATURITY;
BODY WEIGHT;
INTRAVITREAL INJECTIONS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 79959312582
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (6)
|
|
References (3)
|
